헌팅턴병 치료 시장 보고서(2026년)

Huntington's disease treatment consists of medical therapies aimed at managing the symptoms of this progressive neurological disorder. The primary objectives are to slow disease progression, relieve symptoms, and improve the patient's quality of life.

The main types of Huntington's disease treatment include symptomatic treatments and disease-modifying therapies. Symptomatic treatments focus on easing symptoms and enhancing quality of life without targeting the underlying cause, and are increasingly sought after to help patients manage daily challenges. These therapies can be administered orally, intravenously, subcutaneously, or topically for applications in genetic, neurological, and psychiatric disorders. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are used by hospitals, clinics, home care settings, research institutions, and other healthcare facilities.

Tariffs have affected the huntington's disease treatment market by increasing the cost of imported active pharmaceutical ingredients, biologic components, and advanced therapy manufacturing inputs used in neurological drugs. These impacts have been most pronounced in disease-modifying and gene therapy segments, particularly in North America and Europe where cross-border clinical development and API sourcing are common. Asia-Pacific manufacturers have faced pricing pressures due to trade dependencies on specialized raw materials. However, tariffs have encouraged localized production and regional clinical manufacturing, supporting long-term supply resilience.

The huntington's disease treatment market research report is one of a series of new reports from The Business Research Company that provides huntington's disease treatment market statistics, including huntington's disease treatment industry global market size, regional shares, competitors with a huntington's disease treatment market share, detailed huntington's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the huntington's disease treatment industry. This huntington's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The huntington's disease treatment market size has grown rapidly in recent years. It will grow from $0.82 billion in 2025 to $0.92 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to limited treatment options for neurodegenerative disorders, increasing diagnosis of genetic neurological diseases, early reliance on symptomatic management, expansion of neurology specialty care, growth in hospital-based neurological treatments.

The huntington's disease treatment market size is expected to see rapid growth in the next few years. It will grow to $1.48 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to advancements in gene therapy technologies, rising investment in rare disease research, increasing orphan drug designations, growing precision medicine adoption, expanding pipeline of disease-modifying therapies. Major trends in the forecast period include growing focus on disease-modifying therapies, increasing adoption of gene and RNA-based treatments, expansion of combination therapy approaches, rising emphasis on symptom-specific drug development, increasing clinical trial activity for rare neurological disorders.

The rising adoption of gene therapies is expected to drive the growth of the Huntington's disease treatment market in the coming years. Gene therapies are treatments that modify or replace defective genes to prevent or cure diseases at the genetic level. Their growth is fueled by advances in precision medicine, which allow for the direct targeting of genetic causes and improved outcomes compared to traditional treatments. In Huntington's disease, gene therapies work by silencing the defective HTT gene that produces harmful proteins, thereby preventing nerve cell damage. This approach helps slow disease progression, preserve brain function, and offers potential for long-term disease management. For example, in July 2023, the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drug and device data, reported that the number of gene therapies in phase II increased from 247 at the end of Q1 2023 to 260 by the end of Q2, reflecting a 5% growth. Consequently, the expansion of gene therapies is propelling the Huntington's disease treatment market.

Leading companies in the Huntington's disease treatment market are focusing on developing advanced therapies, such as selective vesicular monoamine transporter 2 (VMAT2) inhibitor capsules, to potentially enhance patient quality of life while slowing disease progression. Selective VMAT2 inhibitor capsules are drugs that block the vesicular monoamine transporter 2, a protein responsible for packaging neurotransmitters for release in the brain. By reducing neurotransmitter release, these medications help manage involuntary movements and related symptoms. For example, in August 2023, Neurocrine Biosciences, Inc., a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for Ingrezza (valbenazine) capsules to treat chorea associated with Huntington's disease (HD) in adults. These once-daily oral VMAT2 inhibitor capsules work by decreasing excessive dopamine signaling in the brain to help control involuntary movements. They are available in multiple strengths and can be taken with or without food, providing patients with a convenient dosing option.

In December 2024, PTC Therapeutics Inc., a US-based pharmaceutical company developing treatments for Huntington's disease, partnered with Novartis AG to advance a Huntington's disease therapy. This collaboration is intended to accelerate the development and global commercialization of PTC518, a potential first-in-class oral, disease-modifying treatment for Huntington's disease. Novartis AG is a Switzerland-based manufacturer of drugs for Huntington's disease.

Major companies operating in the huntington's disease treatment market are F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeutics Inc., Annexon Inc., Alnylam Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Dr. Reddy's Laboratories Ltd., Lupin Limited, Hikma Pharmaceuticals plc, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., AbbVie Inc.

North America was the largest region in the Huntington's disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington's disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the huntington's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Huntington's disease treatment market consists of sales of products including tetrabenazine, deutetrabenazine, huntingtin-lowering therapies, cannabinoids, and cognitive enhancers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Huntington's Disease Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses huntington's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for huntington's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The huntington's disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment: Symptomatic Treatment; Disease-Modifying Therapies
• 2) By Administration Type: Oral; Intravenous; Subcutaneous; Topical
• 3) By Therapeutic: Genetic Disorders; Neurological Disorders; Psychiatric Disorders
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End-User: Hospitals; Clinics; Homecare Settings; Research Centers
• Subsegments:
• 1) By Symptomatic Treatment: Antidepressants; Antipsychotics; Mood Stabilizers; Chorea Medications; Cognitive Enhancers
• 2) By Disease-Modifying Therapies: Gene Therapy; Neuroprotective Agents; RNA-Based Therapies; Stem Cell Therapy; Protein-Targeting Therapies
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Teva Pharmaceutical Industries Ltd.; H. Lundbeck A/S; Neurocrine Biosciences Inc.; Wave Life Sciences Ltd.; PTC Therapeutics Inc.; Ionis Pharmaceuticals Inc.; uniQure N.V.; Prilenia Therapeutics B.V.; Sage Therapeutics Inc.; Annexon Inc.; Alnylam Pharmaceuticals Inc.; Sun Pharmaceutical Industries Inc.; Dr. Reddy's Laboratories Ltd.; Lupin Limited; Hikma Pharmaceuticals plc; Astellas Pharma Inc.; Otsuka Pharmaceutical Co. Ltd.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Huntington's Disease Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Huntington's Disease Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Huntington's Disease Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Huntington's Disease Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Growing Focus On Disease-Modifying Therapies
  • 4.2.2 Increasing Adoption Of Gene And Rna-Based Treatments
  • 4.2.3 Expansion Of Combination Therapy Approaches
  • 4.2.4 Rising Emphasis On Symptom-Specific Drug Development
  • 4.2.5 Increasing Clinical Trial Activity For Rare Neurological Disorders

5. Huntington's Disease Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Homecare Settings
• 5.4 Research Centers
• 5.5 Specialty Neurology Centers

6. Huntington's Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Huntington's Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Huntington's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Huntington's Disease Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Huntington's Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Huntington's Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Huntington's Disease Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Huntington's Disease Treatment Market Segmentation

• 9.1. Global Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Symptomatic Treatment, Disease-Modifying Therapies
• 9.2. Global Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Intravenous, Subcutaneous, Topical
• 9.3. Global Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Disorders, Neurological Disorders, Psychiatric Disorders
• 9.4. Global Huntington's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Huntington's Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Homecare Settings, Research Centers
• 9.6. Global Huntington's Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers
• 9.7. Global Huntington's Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, Stem Cell Therapy, Protein-Targeting Therapies

10. Huntington's Disease Treatment Market Regional And Country Analysis

• 10.1. Global Huntington's Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Huntington's Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Huntington's Disease Treatment Market

• 11.1. Asia-Pacific Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Huntington's Disease Treatment Market

• 12.1. China Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Huntington's Disease Treatment Market

• 13.1. India Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Huntington's Disease Treatment Market

• 14.1. Japan Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Huntington's Disease Treatment Market

• 15.1. Australia Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Huntington's Disease Treatment Market

• 16.1. Indonesia Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Huntington's Disease Treatment Market

• 17.1. South Korea Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Huntington's Disease Treatment Market

• 18.1. Taiwan Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Huntington's Disease Treatment Market

• 19.1. South East Asia Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Huntington's Disease Treatment Market

• 20.1. Western Europe Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Huntington's Disease Treatment Market

• 21.1. UK Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Huntington's Disease Treatment Market

• 22.1. Germany Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Huntington's Disease Treatment Market

• 23.1. France Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Huntington's Disease Treatment Market

• 24.1. Italy Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Huntington's Disease Treatment Market

• 25.1. Spain Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Huntington's Disease Treatment Market

• 26.1. Eastern Europe Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Huntington's Disease Treatment Market

• 27.1. Russia Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Huntington's Disease Treatment Market

• 28.1. North America Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Huntington's Disease Treatment Market

• 29.1. USA Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Huntington's Disease Treatment Market

• 30.1. Canada Huntington's Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Huntington's Disease Treatment Market

• 31.1. South America Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Huntington's Disease Treatment Market

• 32.1. Brazil Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Huntington's Disease Treatment Market

• 33.1. Middle East Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Huntington's Disease Treatment Market

• 34.1. Africa Huntington's Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Huntington's Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Huntington's Disease Treatment Market Regulatory and Investment Landscape

36. Huntington's Disease Treatment Market Competitive Landscape And Company Profiles

• 36.1. Huntington's Disease Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Huntington's Disease Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Huntington's Disease Treatment Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. H. Lundbeck A/S Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Neurocrine Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Huntington's Disease Treatment Market Other Major And Innovative Companies

• Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeutics Inc., Annexon Inc., Alnylam Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Dr. Reddy's Laboratories Ltd., Lupin Limited, Hikma Pharmaceuticals plc, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., AbbVie Inc.

38. Global Huntington's Disease Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Huntington's Disease Treatment Market

40. Huntington's Disease Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Huntington's Disease Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Huntington's Disease Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Huntington's Disease Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer